Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 243 entries
Sorted by: Best Match Show Resources per page
Increasing achievement by focusing grade-level teams on improving classroom learning: A prospective, quasi-experimental study of Title I schools

quasi-experimental designs

Goldenberg CN, Gallimore R.
GSID: Iz7sLrnX-bgJ
WM Saunders, CN Goldenberg, R Gallimore - 2009 - journals.sagepub.com

… In this article, we present a brief review and critique of the research base and describe a 5-year quasi-experimental investigation comparing … This might be one of the first quasi-experimental investigations demonstrating increased average achievement over time in...

Cite
Saunders, W. M., Goldenberg, C. N., & Gallimore, R. (2009). Increasing achievement by focusing grade-level teams on improving classroom learning: A prospective, quasi-experimental study of Title I schools.
Saunders, William M., Claude N. Goldenberg, and Ronald Gallimore. "Increasing achievement by focusing grade-level teams on improving classroom learning: A prospective, quasi-experimental study of Title I schools." (2009): 1006-1033.
Copy Download .nbib Format: MLA
Global network for women's and children's health research: a system for low-resource areas to determine probable causes of stillbirth, neonatal, and maternal death.

Maternal health, neonatology and perinatology

McClure EM, Bose CL, Garces A, Esamai F, Goudar SS, Patel A, Chomba E, Pasha O, Tshefu A, Kodkany BS, Saleem S, Carlo WA, Derman RJ, Hibberd PL, Liechty EA, Hambidge KM, Krebs NF, Bauserman M, Koso-Thomas M, Moore J, Wallace DD, Jobe AH, Goldenberg RL.
PMID: 27057328
Matern Health Neonatol Perinatol. 2015 May 04;1:11. doi: 10.1186/s40748-015-0012-7. eCollection 2015.

BACKGROUND: Determining cause of death is needed to develop strategies to reduce maternal death, stillbirth, and newborn death, especially for low-resource settings where 98% of deaths occur. Most existing classification systems are designed for high income settings where extensive...

Cite
McClure EM, Bose CL, Garces A, et al. Global network for women's and children's health research: a system for low-resource areas to determine probable causes of stillbirth, neonatal, and maternal death. Matern Health Neonatol Perinatol. 2015;1:11doi: 10.1186/s40748-015-0012-7.
McClure, E. M., Bose, C. L., Garces, A., Esamai, F., Goudar, S. S., Patel, A., Chomba, E., Pasha, O., Tshefu, A., Kodkany, B. S., Saleem, S., Carlo, W. A., Derman, R. J., Hibberd, P. L., Liechty, E. A., Hambidge, K. M., Krebs, N. F., Bauserman, M., Koso-Thomas, M., Moore, J., Wallace, D. D., Jobe, A. H., & Goldenberg, R. L. (2015). Global network for women's and children's health research: a system for low-resource areas to determine probable causes of stillbirth, neonatal, and maternal death. Maternal health, neonatology and perinatology, 111. https://doi.org/10.1186/s40748-015-0012-7
McClure, Elizabeth M, et al. "Global network for women's and children's health research: a system for low-resource areas to determine probable causes of stillbirth, neonatal, and maternal death." Maternal health, neonatology and perinatology vol. 1 (2015): 11. doi: https://doi.org/10.1186/s40748-015-0012-7
McClure EM, Bose CL, Garces A, Esamai F, Goudar SS, Patel A, Chomba E, Pasha O, Tshefu A, Kodkany BS, Saleem S, Carlo WA, Derman RJ, Hibberd PL, Liechty EA, Hambidge KM, Krebs NF, Bauserman M, Koso-Thomas M, Moore J, Wallace DD, Jobe AH, Goldenberg RL. Global network for women's and children's health research: a system for low-resource areas to determine probable causes of stillbirth, neonatal, and maternal death. Matern Health Neonatol Perinatol. 2015 May 04;1:11. doi: 10.1186/s40748-015-0012-7. eCollection 2015. PMID: 27057328; PMCID: PMC4823684.
Copy Download .nbib Format: NLM
Comparison between effects of pressure support and pressure-controlled ventilation on lung and diaphragmatic damage in experimental emphysema.

Intensive care medicine experimental

Padilha GA, Horta LF, Moraes L, Braga CL, Oliveira MV, Santos CL, Ramos IP, Morales MM, Capelozzi VL, Goldenberg RC, de Abreu MG, Pelosi P, Silva PL, Rocco PR.
PMID: 27761886
Intensive Care Med Exp. 2016 Dec;4(1):35. doi: 10.1186/s40635-016-0107-0. Epub 2016 Oct 19.

BACKGROUND: In patients with emphysema, invasive mechanical ventilation settings should be adjusted to minimize hyperinflation while reducing respiratory effort and providing adequate gas exchange. We evaluated the impact of pressure-controlled ventilation (PCV) and pressure support ventilation (PSV) on pulmonary...

Cite
Padilha GA, Horta LF, Moraes L, et al. Comparison between effects of pressure support and pressure-controlled ventilation on lung and diaphragmatic damage in experimental emphysema. Intensive Care Med Exp. 2016;4(1):35doi: 10.1186/s40635-016-0107-0.
Padilha, G. A., Horta, L. F., Moraes, L., Braga, C. L., Oliveira, M. V., Santos, C. L., Ramos, I. P., Morales, M. M., Capelozzi, V. L., Goldenberg, R. C., de Abreu, M. G., Pelosi, P., Silva, P. L., & Rocco, P. R. (2016). Comparison between effects of pressure support and pressure-controlled ventilation on lung and diaphragmatic damage in experimental emphysema. Intensive care medicine experimental, 4(1), 35. https://doi.org/10.1186/s40635-016-0107-0
Padilha, Gisele de A, et al. "Comparison between effects of pressure support and pressure-controlled ventilation on lung and diaphragmatic damage in experimental emphysema." Intensive care medicine experimental vol. 4,1 (2016): 35. doi: https://doi.org/10.1186/s40635-016-0107-0
Padilha GA, Horta LF, Moraes L, Braga CL, Oliveira MV, Santos CL, Ramos IP, Morales MM, Capelozzi VL, Goldenberg RC, de Abreu MG, Pelosi P, Silva PL, Rocco PR. Comparison between effects of pressure support and pressure-controlled ventilation on lung and diaphragmatic damage in experimental emphysema. Intensive Care Med Exp. 2016 Dec;4(1):35. doi: 10.1186/s40635-016-0107-0. Epub 2016 Oct 19. PMID: 27761886; PMCID: PMC5071308.
Copy Download .nbib Format: NLM
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Berard L, Antonishyn N, Arcudi K, Blunden S, Cheng A, Goldenberg R, Harris S, Jones S, Mehan U, Morrell J, Roscoe R, Siemens R, Vallis M, Yale JF.
PMID: 29476414
Diabetes Ther. 2018 Apr;9(2):501-519. doi: 10.1007/s13300-018-0375-7. Epub 2018 Feb 23.

It is currently estimated that 11 million Canadians are living with diabetes or prediabetes. Although hyperglycemia is associated with serious complications, it is well established that improved glycemic control reduces the risk of microvascular complications and can also reduce...

Cite
Berard L, Antonishyn N, Arcudi K, et al. Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes. Diabetes Ther. 2018;9(2):501-519doi: 10.1007/s13300-018-0375-7.
Berard, L., Antonishyn, N., Arcudi, K., Blunden, S., Cheng, A., Goldenberg, R., Harris, S., Jones, S., Mehan, U., Morrell, J., Roscoe, R., Siemens, R., Vallis, M., & Yale, J. F. (2018). Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders, 9(2), 501-519. https://doi.org/10.1007/s13300-018-0375-7
Berard, Lori, et al. "Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 9,2 (2018): 501-519. doi: https://doi.org/10.1007/s13300-018-0375-7
Berard L, Antonishyn N, Arcudi K, Blunden S, Cheng A, Goldenberg R, Harris S, Jones S, Mehan U, Morrell J, Roscoe R, Siemens R, Vallis M, Yale JF. Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes. Diabetes Ther. 2018 Apr;9(2):501-519. doi: 10.1007/s13300-018-0375-7. Epub 2018 Feb 23. PMID: 29476414; PMCID: PMC6104258.
Copy Download .nbib Format: NLM
Crystal structures of three (trichloromethyl)(carbamoyl)disulfanes.

Acta crystallographica. Section E, Crystallographic communications

Goldenberg BL, Young VG, Barany G.
PMID: 26594398
Acta Crystallogr E Crystallogr Commun. 2015 Sep 12;71:1169-73. doi: 10.1107/S2056989015015893. eCollection 2015 Oct 01.

The present paper reports crystallographic studies on three related compounds that were of inter-est as precursors for synthetic and mechanistic work in organosulfur chemistry, as well as to model nitro-gen-protecting groups: (N-methyl-carbamo-yl)(tri-chloro-meth-yl)disulfane, C3H4Cl3NOS2, (1), (N-benzyl-carbamo-yl)(tri-chloro-meth-yl)disulfane, C9H8Cl3NOS2, (2), and (N-methyl-N-phenyl-carbamo-yl)(tri-chloro-meth-yl)disulfane,...

Cite
Goldenberg BL, Young VG, Barany G. Crystal structures of three (trichloromethyl)(carbamoyl)disulfanes. Acta Crystallogr E Crystallogr Commun. 2015;71:1169-73doi: 10.1107/S2056989015015893.
Goldenberg, B. L., Young, V. G., & Barany, G. (2015). Crystal structures of three (trichloromethyl)(carbamoyl)disulfanes. Acta crystallographica. Section E, Crystallographic communications, 711169-73. https://doi.org/10.1107/S2056989015015893
Goldenberg, Barbara L, et al. "Crystal structures of three (trichloromethyl)(carbamoyl)disulfanes." Acta crystallographica. Section E, Crystallographic communications vol. 71 (2015): 1169-73. doi: https://doi.org/10.1107/S2056989015015893
Goldenberg BL, Young VG, Barany G. Crystal structures of three (trichloromethyl)(carbamoyl)disulfanes. Acta Crystallogr E Crystallogr Commun. 2015 Sep 12;71:1169-73. doi: 10.1107/S2056989015015893. eCollection 2015 Oct 01. PMID: 26594398; PMCID: PMC4647414.
Copy Download .nbib Format: NLM
A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Millar AC, Elterman DS, Goldenberg L, Van Asseldonk B, Curtis A, Jarvi K.
PMID: 27713795
Can Urol Assoc J. 2016 May-Jun;10(5):181-184. doi: 10.5489/cuaj.3608.

INTRODUCTION: Attitudes regarding the safety of testosterone replacement therapy (TRT) in hypogonadal men with prostate cancer (PCa) have changed over the past few years with the emergence of case studies suggesting a low risk of cancer progression and a...

Cite
Millar AC, Elterman DS, Goldenberg L, et al. A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer. Can Urol Assoc J. 2016;10(5):181-184doi: 10.5489/cuaj.3608.
Millar, A. C., Elterman, D. S., Goldenberg, L., Van Asseldonk, B., Curtis, A., & Jarvi, K. (2016). A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 10(5), 181-184. https://doi.org/10.5489/cuaj.3608
Millar, Adam C, et al. "A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 10,5 (2016): 181-184. doi: https://doi.org/10.5489/cuaj.3608
Millar AC, Elterman DS, Goldenberg L, Van Asseldonk B, Curtis A, Jarvi K. A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer. Can Urol Assoc J. 2016 May-Jun;10(5):181-184. doi: 10.5489/cuaj.3608. PMID: 27713795; PMCID: PMC5045343.
Copy Download .nbib Format: NLM
Radiofluorination using aluminum-fluoride (Al18F).

EJNMMI research

McBride WJ, Sharkey RM, Goldenberg DM.
PMID: 23651690
EJNMMI Res. 2013 May 08;3(1):36. doi: 10.1186/2191-219X-3-36.

Targeted agents are increasingly used for treating cancer and other diseases, but patients may need to be carefully selected to maximize the potential for therapeutic benefit. One way to select patients is to bind an imaging radionuclide to a...

Cite
McBride WJ, Sharkey RM, Goldenberg DM. Radiofluorination using aluminum-fluoride (Al18F). EJNMMI Res. 2013;3(1):36doi: 10.1186/2191-219X-3-36.
McBride, W. J., Sharkey, R. M., & Goldenberg, D. M. (2013). Radiofluorination using aluminum-fluoride (Al18F). EJNMMI research, 3(1), 36. https://doi.org/10.1186/2191-219X-3-36
McBride, William J, et al. "Radiofluorination using aluminum-fluoride (Al18F)." EJNMMI research vol. 3,1 (2013): 36. doi: https://doi.org/10.1186/2191-219X-3-36
McBride WJ, Sharkey RM, Goldenberg DM. Radiofluorination using aluminum-fluoride (Al18F). EJNMMI Res. 2013 May 08;3(1):36. doi: 10.1186/2191-219X-3-36. PMID: 23651690; PMCID: PMC3665500.
Copy Download .nbib Format: NLM
Hydronephrosis after simple hysterectomy for benign disease: a prospective study.

The Canadian journal of urology

Woo HL, Goldenberg SL, Simpson ML, Cooperberg PL.
PMID: 12735809
Can J Urol. 1997 Dec;4(4):445-446.

OBJECTIVES: To determine the prevalence and implications of transient asymptomatic hydronephrosis following simple hysterectomy for benign disease. METHODS: Over a 12-month period, 50 consecutive women undergoing total abdominal hysterectomy with or without bilateral salpingo-oophorectomy were evaluated. Renal ultrasound to...

Cite
Woo HL, Goldenberg SL, Simpson ML, et al. Hydronephrosis after simple hysterectomy for benign disease: a prospective study. Can J Urol. 1997;4(4):445-446
Woo, H. L., Goldenberg, S. L., Simpson, M. L., & Cooperberg, P. L. (1997). Hydronephrosis after simple hysterectomy for benign disease: a prospective study. The Canadian journal of urology, 4(4), 445-446.
Woo, Henry L., et al. "Hydronephrosis after simple hysterectomy for benign disease: a prospective study." The Canadian journal of urology vol. 4,4 (1997): 445-446.
Woo HL, Goldenberg SL, Simpson ML, Cooperberg PL. Hydronephrosis after simple hysterectomy for benign disease: a prospective study. Can J Urol. 1997 Dec;4(4):445-446. PMID: 12735809.
Copy Download .nbib Format: NLM
Prostatism: nature of the symptoms.

The Canadian journal of urology

Goldenberg SL.
PMID: 12735827
Can J Urol. 1997 Jun;4(2):3-5.

Benign prostatic hyperplasia (BPH) is very common. Almost 80% of men over the age of 70 have at least histological evidence of this process. The clinical prevalence of BPH increases from 10% in the fourth decade to approximately 40%...

Cite
Goldenberg SL. Prostatism: nature of the symptoms. Can J Urol. 1997;4(2):3-5
Goldenberg, S. L. (1997). Prostatism: nature of the symptoms. The Canadian journal of urology, 4(2), 3-5.
Goldenberg, S. Larry. "Prostatism: nature of the symptoms." The Canadian journal of urology vol. 4,2 (1997): 3-5.
Goldenberg SL. Prostatism: nature of the symptoms. Can J Urol. 1997 Jun;4(2):3-5. PMID: 12735827.
Copy Download .nbib Format: NLM
Immunohistochemical Analysis of Radical Prostatectomy Specimens After 8 Months of Neoadjuvant Hormonal Therapy.

Molecular urology

Paterson RF, Gleave ME, Jones EC, Zubovits JT, Goldenberg SL, Sullivan LD.
PMID: 10851334
Mol Urol. 1999;3(3):277-286.

Neoadjuvant hormone therapy (NHT) prior to radical prostatectomy (RP) results in residual foci of atrophic glands, which can be difficult to identify with hematoxylin-eosin staining, raising the possibility that the low positive-margin rates are an artifact of pathologic understaging....

Cite
Paterson RF, Gleave ME, Jones EC, et al. Immunohistochemical Analysis of Radical Prostatectomy Specimens After 8 Months of Neoadjuvant Hormonal Therapy. Mol Urol. 1999;3(3):277-286
Paterson, R. F., Gleave, M. E., Jones, E. C., Zubovits, J. T., Goldenberg, S. L., & Sullivan, L. D. (1999). Immunohistochemical Analysis of Radical Prostatectomy Specimens After 8 Months of Neoadjuvant Hormonal Therapy. Molecular urology, 3(3), 277-286.
Paterson, et al. "Immunohistochemical Analysis of Radical Prostatectomy Specimens After 8 Months of Neoadjuvant Hormonal Therapy." Molecular urology vol. 3,3 (1999): 277-286.
Paterson RF, Gleave ME, Jones EC, Zubovits JT, Goldenberg SL, Sullivan LD. Immunohistochemical Analysis of Radical Prostatectomy Specimens After 8 Months of Neoadjuvant Hormonal Therapy. Mol Urol. 1999;3(3):277-286. PMID: 10851334.
Copy Download .nbib Format: NLM
Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up.

Molecular urology

Goldenberg SL, Gleave ME, Taylor D, Bruchovsky N.
PMID: 10851335
Mol Urol. 1999;3(3):287-292.

This report reviews the long-term follow-up of a prospective Phase II evaluation of intermittent androgen suppression in the treatment of prostate cancer. A total of 87 patients have been entered in this protocol. At the time of this report,...

Cite
Goldenberg SL, Gleave ME, Taylor D, et al. Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up. Mol Urol. 1999;3(3):287-292
Goldenberg, S. L., Gleave, M. E., Taylor, D., & Bruchovsky, N. (1999). Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up. Molecular urology, 3(3), 287-292.
Goldenberg, et al. "Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up." Molecular urology vol. 3,3 (1999): 287-292.
Goldenberg SL, Gleave ME, Taylor D, Bruchovsky N. Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up. Mol Urol. 1999;3(3):287-292. PMID: 10851335.
Copy Download .nbib Format: NLM
Alpha-blocker therapy for benign prostatic hyperplasia: a comparative review.

The Canadian journal of urology

Goldenberg SL, Ramsey E, Trachtenberg J.
PMID: 11299113
Can J Urol. 1998 Jun;5(2):551-557.

In the past decade there has been a shift in the primary approach to therapy for BPH, from surgical intervention to pharmacotherapy. Therapies with alpha-blockers, particularly long-acting selective alpha1-adrenoreceptor antagonists, has proven effective, and hence has become a popular...

Cite
Goldenberg SL, Ramsey E, Trachtenberg J. Alpha-blocker therapy for benign prostatic hyperplasia: a comparative review. Can J Urol. 1998;5(2):551-557
Goldenberg, S. L., Ramsey, E., & Trachtenberg, J. (1998). Alpha-blocker therapy for benign prostatic hyperplasia: a comparative review. The Canadian journal of urology, 5(2), 551-557.
Goldenberg, S. Larry, et al. "Alpha-blocker therapy for benign prostatic hyperplasia: a comparative review." The Canadian journal of urology vol. 5,2 (1998): 551-557.
Goldenberg SL, Ramsey E, Trachtenberg J. Alpha-blocker therapy for benign prostatic hyperplasia: a comparative review. Can J Urol. 1998 Jun;5(2):551-557. PMID: 11299113.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 243 entries